USFDA grants priority review to Merck application for Keytruda plus chemotherapy for Metastatic Malignant Pleural Mesothelioma Ruchika Sharma1 Jun 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Merck unveils Software for Complete Data Traceability in Microbial QC Ruchika Sharma29 May 2024 3:05 PM ISTMerck, a science and technology company, has launched its M-Trace Software & Mobile App, a comprehensive data tracking solution to digitize...
Merck close to sealing USD 1.3 billion cash deal for Eyebiotech: Report Ruchika Sharma29 May 2024 10:15 AM ISTLondon: Merck & Co is close to finalizing a cash acquisition deal worth $1.3 billion for Eyebiotech, a biotechnology company specializing in...
MSD Animal Health gets European Commission marketing nod for INNOVAX-ND-H5 vaccine for chickens Ruchika Sharma28 May 2024 9:00 AM ISTRahway: MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, has announced that the European Commission has granted the...
Merck discontinues Vibostolimab, Pembrolizumab coformulation arm of Phase 3 KeyVibe-010 trial in Melanoma Ruchika Sharma14 May 2024 4:17 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the vibostolimab and pembrolizumab...
Phase 3 trial evaluating Keytruda in endometrial cancer misses primary survival endpoint: Merck Ruchika Sharma11 May 2024 12:41 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYNOTE-B21 trial evaluating KEYTRUDA,...
Merck gets Canadian nod for Keytruda in combo with fluoropyrimidine- and platinum-containing-chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma Ruchika Sharma23 April 2024 3:08 PM ISTKirkland: Merck, known as MSD outside the United States and Canada, has announced that Health Canada has granted approval of KEYTRUDA...
Merck unveils all-in-one genetic stability assay to accelerate biosafety testing Ruchika Sharma21 April 2024 5:37 PM ISTGermany: Merck, a science and technology company, has launched the all-in-one, validated genetic stability assay of its kind. The Aptegra CHO...
Merck begins phase 3 trial of MK-1084, Keytruda combo for first-line treatment of certain patients with Metastatic Non-Small Cell Lung Cancer Ruchika Sharma6 April 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced it has initiated a Phase 3 clinical trial evaluating MK-1084,...
European Commission approves Merck Keytruda plus Chemotherapy for lung cancer Ruchika Sharma1 April 2024 5:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved KEYTRUDA,...
Merck gets USFDA nod for WINREVAIR (sotatercept-csrk) for adults with pulmonary arterial hypertension Ruchika Sharma27 March 2024 11:51 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
Merck Speciality gets CDSCO Panel Nod To study anti-cancer drug Avelumab Dr. Divya Colin22 March 2024 5:45 PM ISTNew Delhi: The drug major Merck Speciality has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
